Seizure disorders – including Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS), and other complex epilepsies – demand sophisticated understanding of disease presentation, treatment complexity, seizure control, patient outcomes, and caregiver burden across diverse care settings. As the therapeutic landscape expands with novel antiepileptic agents, specialized seizure management strategies, and emerging targeted interventions, obtaining high-quality real-world evidence is critical to support clinical strategies, inform healthcare decisions, and demonstrate clinical and quality-of-life value to key stakeholders.
Adelphi Real World’s Disease Specific Programmes (DSPs) are purpose-built to address these challenges.
Our Seizure Disorder DSPs provide comprehensive, actionable real-world data and insights tailored to the distinctive features of epilepsy recurrence and seizure management. By engaging directly with epilepsy specialists, neurologists, patients, and caregivers, our DSPs deliver granular perspectives on:
Treatment Sequencing & Management Patterns
Understand real-world therapy selection, combination strategies, and sequential treatment approaches across seizure disorder types, disease stages, patient demographics, and healthcare systems – capturing adoption of emerging therapies and treatment decision pathways in routine epilepsy practice.
Physician Decision-Making
Explore the clinical reasoning behind treatment choices, factors influencing therapy selection in better-controlled versus highly-refractory seizure disorders, seizure type-specific management strategies, seizure action plans, rescue therapy approaches, strategies for timely recognition and intervention of seizures, and seizure burden assessment.
Patient & Caregiver Experiences & Outcomes
Document real-world efficacy, tolerability profiles, seizure control, seizure frequency reduction, medication side effects, developmental preservation, quality of life, caregiver burden, support needs, and lived experiences in everyday clinical settings – revealing gaps between trial data and real-world patient and family experience across seizure disorder populations.
Emerging Unmet Needs
Uncover persistent treatment challenges, gaps in seizure management, emerging therapeutic opportunities, drug-resistant seizure prevention strategies, comorbidity management, safety concerns, medication adherence barriers, caregiver support gaps, and opportunities for therapeutic innovation and positioning to better serve patients with seizure disorders.
Seizure Disorder Disease Specific Programmes (DSP) Portfolio
Why Partner With Adelphi Real World for Seizure Disorder Research?
Extensive Global Coverage
Our DSP network spans multiple countries, providing robust comparative insights into seizure disorder practice, treatment adoption, diagnostic approaches, and healthcare delivery across diverse healthcare systems.
Deep Clinical Expertise
With specialised knowledge of seizure disorders, we ensure our data collection, analysis, and interpretation reflect the true complexity of epilepsy management and the needs of treating clinicians and supporting caregivers.
Evidence That Drives Impact
From clinical development to reimbursement and healthcare provider engagement, our seizure disorder DSPs provide the credible, compelling evidence needed to influence decisions across the healthcare ecosystem.
Seizure Disorder DSP Coverage
Who We Work With
We partner strategically with biopharmaceutical innovators, neurology practices, epilepsy specialist centres, hospital networks, specialized seizure management facilities, paediatric neurology centres, patient support organisations, caregiver advocacy groups, and healthcare policymakers to generate evidence that transforms seizure disorder care globally.
Let’s Get Started
- Schedule a Consultation: Meet with our seizure disorder specialists to discuss how our DSPs can support your research, development, and market access objectives across Dravet Syndrome, Lennox-Gastaut Syndrome, and other seizure disorders.
- Get More Details: Want to explore our methodology, disease focus areas, global reach, caregiver insights, or specialist networks? We’re here to answer your questions and provide customised information.
Adelphi Real World brings together real-world expertise, seizure disorder insight, and global reach to help you succeed in epilepsy research. Let’s collaborate to advance evidence and improve outcomes for patients with seizure disorders.
Contact us today using the form below.
Conferences Attending
Observational Research